Emma Pozzi

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life

Raffaella Palumbo, Federico Sottotetti, Giuseppe Trifirò et al. · Drug Design Development and Therapy · 2015 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians

Raffaella Palumbo, Federico Sottotetti, Alberto Riccardi et al. · Therapeutic Advances in Medical Oncology · 2013 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver.

Guido Poggi, Emma Pozzi, Alberto Riccardi et al. · PubMed · 2010 · 35 citations

Medicine, Oncology, Surgery +16

Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study

Matteo Lambertini, Arlindo R. Ferreira, Francesca Poggio et al. · The Oncologist · 2015 · 26 citations · Full text

Medicine, Oncology, Breast Oncology +14

Influence of different lipid emulsions on specific immune cell functions in head and neck cancer patients receiving supplemental parenteral nutrition: An exploratory analysis

Francesca Candiloro, Valeria Borioli, Giovanna Borsellino et al. · Nutrition · 2021 · 14 citations · Full text

Agriculture, Immunology, Nutrition +17